Breaking News
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics
November 17, 2018 - FDA approves antibacterial drug to treat travelers’ diarrhea
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - UCLA biologists uncover how head injuries can lead to serious brain disorders
November 17, 2018 - Static and dynamic physical activities offer varying protection against heart disease
November 17, 2018 - Obesity significantly increases risk of Type 2 diabetes and coronary artery disease
November 17, 2018 - People with rare cancers can benefit from genomic profiling, shows research
November 17, 2018 - NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach
November 17, 2018 - Four-in-one antibody used to fight flu shows promise in mice
November 17, 2018 - New approach allows pathogens to be starved by blocking important enzymes
November 17, 2018 - Higher body mass index could cause depression even without health problems
November 17, 2018 - Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension
November 17, 2018 - FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
November 17, 2018 - ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
November 17, 2018 - UT Southwestern scientists selected to receive 2019 Edith and Peter O’Donnell Awards
November 17, 2018 - New clinical algorithm to help individuals manage type 2 diabetes when fasting during Ramadan
November 17, 2018 - Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway
November 17, 2018 - Heart Disease Leading Cause of Death in Low-Income Counties
November 17, 2018 - Estrogen Levels Test: MedlinePlus Lab Test Information
November 17, 2018 - Research reveals link between immunity, diabetes
November 17, 2018 - Research shows how to achieve improved smoking cessation outcomes within California’s Medicaid population
November 17, 2018 - New study finds less understanding and implementation of patient engagement
November 17, 2018 - New shoe insole technology could help diabetic ulcers heal better while walking
November 17, 2018 - New method to extend cell division and immortalization of avian-derived cells
November 17, 2018 - Australian Academy of Science urges parents to vaccinate children against meningococcal disease
November 17, 2018 - Hot water treatment may help improve inflammation and metabolism in sedentary people
November 17, 2018 - Researchers produce 3D chemical maps of small biological samples
November 17, 2018 - Must Blood Pressure Rise Wth Age? Remote Tribes Hold Clues
November 17, 2018 - Noonan Syndrome
November 17, 2018 - Interventions to delay and prevent type 2 diabetes are underused, researchers say
November 17, 2018 - Hackathon prize winner seeks to remotely monitor patient skin conditions
November 17, 2018 - Research team identifies Ashkenazi Jewish founder mutation for Leigh syndrome
November 17, 2018 - Gene editing could be used to halt kidney disease in patients with Joubert syndrome
November 17, 2018 - Study uncovers link between gut disruption and aging
November 17, 2018 - Teens more likely to pick up smoking after exposure from friends and family
November 17, 2018 - Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence
November 17, 2018 - new horizon in dental, oral and craniofacial research
November 17, 2018 - How does poor air quality affect your health?
November 17, 2018 - New device can regulate children’s blood glucose more like natural pancreas
November 17, 2018 - Game-Changers in Western Blotting and Protein Analysis
November 17, 2018 - FDA announces new actions to limit sale of e-cigarettes to youth
November 17, 2018 - Warmer winter temperatures related to higher crime rates
November 17, 2018 - MCO places increasing emphasis on helping people find and access healthy food
November 17, 2018 - Group of students aim to improve malaria diagnosis using old smartphones
November 17, 2018 - Transplantation of feces may protect preterm children from deadly bowel disease
November 17, 2018 - Researchers explore whether low-gluten diets can be recommended for people without allergies
November 17, 2018 - New and better marker for assessing patients after cardiac arrest
November 17, 2018 - For 7-year-old with failing bone marrow, a life-saving transplant | News Center
November 17, 2018 - New first-line treatment for peripheral T-cell lymphoma approved by FDA
November 17, 2018 - Artificial intelligence could be valuable tool to help young victims disclose traumatic testimony
November 17, 2018 - Breakthrough in the treatment of Restless Legs Syndrome
November 16, 2018 - FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
November 16, 2018 - Eagle Books | Native Diabetes Wellness Program
November 16, 2018 - Patients with common heart failure more likely to have lethal heart rhythms
November 16, 2018 - How AI could help veterinarians code their notes | News Center
November 16, 2018 - Bias-based bullying does more harm to students than generalized bullying
November 16, 2018 - Researchers find first direct evidence that cerebellum plays role in cognitive functions
November 16, 2018 - Non-coding genetic variant plays key role in endothelial function and disease incidence
November 16, 2018 - EMA recommends first all-oral treatment to tackle deadly sleeping sickness
November 16, 2018 - Drug used to treat dizziness may slow down growth of triple-negative breast cancer
November 16, 2018 - AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
November 16, 2018 - ‘Orphan’ RNAs make cancer deadlier, but potentially easier to diagnose
November 16, 2018 - Air Cube touches down at hospital | News Center
November 16, 2018 - CRISPR-based tool shown to enhance cell-based immunotherapy
November 16, 2018 - Mechanisms that govern HIV latency differ in the gut and blood, finds study
Defining the biology of autism

Defining the biology of autism

image_pdfDownload PDFimage_print

When approaching faculty to gauge interest in a new Feinberg center focusing on autism, Peter Penzes, Ph.D., Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences, received puzzled responses from some professors and scientists.

“It turns out there are a range of scientists and labs at Northwestern studying various aspects of autism and its development at a basic science level or a clinical level—but many of them didn’t know about each other.”

Penzes hopes those days are in the past with the launch of the new Center for Autism and Neurodevelopment (CAN), a translational science hub that aims to investigate the neurobiology of autism and facilitate the development of new treatments.

Penzes, as director of the center, recruited 28 scientists from basic science, translational and clinical specialties—a bottom-up approach that will both foster collaboration and train the next generation of scientists in the fields of autism and neurodevelopment.

In addition, CAN will host nationally renowned speakers in a monthly seminar series, to inform Northwestern and the larger community about the latest in autism research across the globe.

“This center is the glue that will bring all these people together,” Penzes said.

A Blank Slate

In comparison to other neurological diseases such as Parkinson’s disease or Alzheimer’s disease, the neurobiology of autism is relatively unstudied, according to Penzes.

“Up until ten years ago, all we knew about autism was based on symptoms displayed by patients,” Penzes said.

Today, advances in genomic sequencing technology and the realization that autism is much more common than previously thought—now estimated at one in 68 children—have placed the genetic component of autism at the forefront.

However, even with strong efforts over the past five years, the specific genetic mechanisms remain opaque, according to Penzes. Some children’s autism may be traced back to a single gene, but those cases are rare—more common are hundreds of small gene variations that cumulatively result in an autism spectrum disorder, making it difficult to zero in on the genes that lead to specific neurophysiological changes.

In addition, there’s no established biomarker for autism, further complicating investigations. While diseases such as Parkinson’s or Alzheimer’s have protein deposits that can indicate disease, there’s no objective measure of autism, according to Penzes, making it difficult to determine if a treatment is working, for example.

CAN hopes to build personalized treatments from the ground up, grouping together patients with similar genetic mutations, identifying the exact time and place where normal brain development is diverted off course and developing drugs to treat those biological changes.

Western Blots to Pills and Shots

While identifying groups of patients with similar mutations may sound simple, about 1,000 genes have been linked with autism so far, and that number is only growing. Narrowing the pool by studying conditions linked to autism but with a more homogenous genetic cause is a strategy used by some scientists, including Anis Contractor, Ph.D., professor of Physiology.

Contractor studies fragile X syndrome (FXS), a genetic disorder in which about half of all patients are also diagnosed with autism—making it the single largest monogenic (linked to a mutation in a single gene) cause of autism in the United States. While most genetic mutations that cause autism are rare, patients with FXS have the mutations in a single gene on the X chromosome, so FXS can be used as a laboratory model for certain aspects of autism, including sensory hypersensitivity.

“A lot of patients don’t like loud sounds or don’t like to be touched,” Contractor said. “When I talk to parents of children with autism, some tell me these sensory issues lead to many other problems, because the kids are withdrawn or socially isolated.”

The exact neurobiology behind this symptom is unknown, so Contractor tracked the development of the sensory cortex in mouse models of FXS, finding there were several “critical periods” of synapse formation that were delayed in the mouse model of the disorder.

“The timing of these critical periods has to be perfect—if you mistime them, the whole system doesn’t wire properly,” Contractor said. “In the FXS mouse, the sensory response from the whiskers excites more neurons in the cortex than it should; we think that is partially responsible for the hypersensitivity symptoms.”

Digging deeper, Contractor traced the critical period shift to an imbalance of intracellular chloride. He said a drug originally approved for hypertension could possibly be used to correct the critical period shift, due to its action on chloride transporters in developing neurons.

“They’ve actually conducted clinical trials of this drug in France and given it to children with autism,” Contractor said. “While it was a small population and the drug’s not perfect, it improved behavioral scores significantly.”

Through the Looking Glass

Genetics aren’t the only starting point for the translational pipeline—imaging will also have a role to play at CAN, according to John Csernansky, Ph.D., chair of Psychiatry and Behavioral Sciences.

“Using imaging to better understand brain function in subjects with autism may help us to identify the precise brain circuits that are affected by the disorder, which could lead to new interventions such as drugs or behavioral therapies,” said Csernansky, also the Lizzie Gilman Professor of Psychiatry and Behavioral Sciences. “The new center will help us identify new collaborators and start new projects.”

Techniques are available that can help autistic patients ease into studies that include imaging, according to Csernansky.

“Patients with autism can be uncomfortable being confined in closed spaces, such as the MR scanner,” Csernansky said. “However, individuals with autism can become more comfortable with the MR scanner by having them spend time in a ‘mock’ scanner, which simulates the space and noise of the MR scanner.”

Ahead of the Pack

The field of autism neurobiology is ripe for discovery: It’s historically understudied and new technology now allows scientists to quickly and cheaply sequence a patient’s genome or grow models of a patient’s brain and test therapies.

While other institutions may have some form of autism research initiative, CAN is unique for its singular focus on translational science, according to Penzes.

“Most autism centers are doing only patient care,” Penzes said. “There are very few places where you have 28 scientists from across disciplines that are brought together with the unifying goal of understanding the neurobiology of autism.”

“If there are new drugs for autism, this is where they are going to come from,” Penzes added.


Explore further:
When kids’ autistic brains can’t calm down

Provided by:
Northwestern University

Tagged with:

About author

Related Articles